$3.59 Billion is the total value of HHLR ADVISORS, LTD.'s 30 reported holdings in Q1 2019. The portfolio turnover from Q4 2018 to Q1 2019 was 37.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BGNE | BEIGENE LTDsponsored adr | $585,810,000 | -5.9% | 4,437,953 | 0.0% | 16.32% | -36.8% | |
| JD | JD COM INCspon adr cl a | $453,493,000 | +44.1% | 15,041,243 | 0.0% | 12.63% | -3.3% | |
| TAL | Buy | TAL EDUCATION GROUPsponsored ads | $411,689,000 | +106.4% | 11,410,453 | +52.6% | 11.47% | +38.6% |
| IQ | Buy | IQIYI INCsponsored ads | $300,375,000 | +1683.2% | 12,557,488 | +1008.5% | 8.37% | +1097.0% |
| BABA | ALIBABA GROUP HLDG LTDsponsored ads | $257,588,000 | +33.1% | 1,411,830 | 0.0% | 7.18% | -10.6% | |
| CBPO | CHINA BIOLOGIC PRODS HLDGS I | $251,047,000 | +20.2% | 2,751,200 | 0.0% | 6.99% | -19.3% | |
| FB | New | FACEBOOK INCcl a | $196,628,000 | – | 1,179,600 | +100.0% | 5.48% | – |
| MDLZ | Sell | MONDELEZ INTL INCcl a | $150,482,000 | +6.5% | 3,014,473 | -14.6% | 4.19% | -28.5% |
| BPMC | Buy | BLUEPRINT MEDICINES CORP | $119,956,000 | +55.5% | 1,498,516 | +4.7% | 3.34% | +4.4% |
| FGEN | FIBROGEN INC | $108,879,000 | +17.4% | 2,003,287 | 0.0% | 3.03% | -21.1% | |
| SE | New | SEA LTDsponsored ads | $101,136,000 | – | 4,300,000 | +100.0% | 2.82% | – |
| MLCO | Buy | MELCO RESORTS AND ENTMT LTDadr | $99,299,000 | +21724.0% | 4,395,700 | +16928.4% | 2.77% | +14457.9% |
| ESGR | New | ENSTAR GROUP LIMITED | $94,567,000 | – | 543,487 | +100.0% | 2.63% | – |
| PDD | Buy | PINDUODUO INCsponsored ads | $77,676,000 | +100.1% | 3,132,096 | +81.0% | 2.16% | +34.4% |
| BILI | Buy | BILIBILI INCspons ads rep z | $65,420,000 | +105.9% | 3,452,231 | +58.5% | 1.82% | +38.2% |
| MYOK | Buy | MYOKARDIA INC | $50,742,000 | +21.0% | 975,987 | +13.7% | 1.41% | -18.8% |
| APLS | Buy | APELLIS PHARMACEUTICALS INC | $50,304,000 | +71.0% | 2,579,708 | +15.7% | 1.40% | +14.8% |
| LN | LINE CORPsponsored adr | $42,525,000 | +3.2% | 1,207,763 | 0.0% | 1.18% | -30.7% | |
| BEDU | BRIGHT SCHOLAR ED HLDGS LTDsponsored ads | $41,213,000 | +12.3% | 3,985,797 | 0.0% | 1.15% | -24.6% | |
| KNSA | Buy | KINIKSA PHARMACEUTICALS LTD | $33,156,000 | -15.0% | 1,835,888 | +32.2% | 0.92% | -42.9% |
| TME | TENCENT MUSIC ENTMT GROUPspon ads | $26,616,000 | +36.9% | 1,470,491 | 0.0% | 0.74% | -8.1% | |
| GOSS | New | GOSSAMER BIO INC | $20,316,000 | – | 937,500 | +100.0% | 0.57% | – |
| GTHX | G1 THERAPEUTICS INC | $15,761,000 | -13.3% | 949,431 | 0.0% | 0.44% | -41.8% | |
| SOHU | SOHU COM INCsponsored ads | $13,298,000 | -4.8% | 802,034 | 0.0% | 0.37% | -36.2% | |
| ARVN | ARVINAS INC | $9,225,000 | +14.9% | 625,000 | 0.0% | 0.26% | -22.8% | |
| RCUS | ARCUS BIOSCIENCES INC | $5,308,000 | +16.0% | 425,000 | 0.0% | 0.15% | -22.1% | |
| EIDX | EIDOS THERAPEUTICS INC | $4,188,000 | +70.4% | 178,600 | 0.0% | 0.12% | +14.7% | |
| SFUN | FANG HLDGS LTDadr | $2,025,000 | -5.6% | 1,500,000 | 0.0% | 0.06% | -37.1% | |
| NEW | Sell | PUXIN LTDads | $874,000 | -69.8% | 126,145 | -74.3% | 0.02% | -80.0% |
| EDU | New | NEW ORIENTAL ED & TECH GRP Ispon adr | $252,000 | – | 2,800 | +100.0% | 0.01% | – |
| NTGN | Exit | NEON THERAPEUTICS INC | $0 | – | -312,500 | -100.0% | -0.06% | – |
| PTI | Exit | PROTEOSTASIS THERAPEUTICS IN | $0 | – | -865,923 | -100.0% | -0.12% | – |
| YY | Exit | YY INC | $0 | – | -193,490 | -100.0% | -0.48% | – |
| LOXO | Exit | LOXO ONCOLOGY INC | $0 | – | -131,300 | -100.0% | -0.76% | – |
| SNAP | Exit | SNAP INCcl a | $0 | – | -6,925,129 | -100.0% | -1.58% | – |
| KANG | Exit | IKANG HEALTHCARE GROUP INCsponsored adr | $0 | – | -2,922,834 | -100.0% | -2.47% | – |
| WUBA | Exit | 58 COM INCspon adr rep a | $0 | – | -1,484,641 | -100.0% | -3.34% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-05-15
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BEIGENE LTD | 20 | Q3 2023 | 26.0% |
| JD.COM INC | 20 | Q3 2023 | 13.1% |
| IQIYI INC | 20 | Q3 2023 | 12.3% |
| MONDELEZ INTL INC | 20 | Q3 2023 | 5.9% |
| KINIKSA PHARMACEUTICALS LTD | 20 | Q3 2023 | 1.6% |
| SOHU COM LTD | 20 | Q3 2023 | 0.6% |
| PINDUODUO INC | 19 | Q3 2023 | 16.1% |
| GOSSAMER BIO INC | 19 | Q3 2023 | 2.3% |
| BRIDGEBIO PHARMA INC | 18 | Q3 2023 | 3.4% |
| MELCO RESORTS AND ENTMT LTD | 18 | Q1 2023 | 2.8% |
View HHLR ADVISORS, LTD.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| I-Mab | June 30, 2023 | 15,891,211 | 8.3% |
| BeiGene, Ltd. | February 14, 2023 | 147,043,058 | 10.9% |
| Gossamer Bio, Inc. | February 14, 2023 | 4,974,041 | 5.3% |
| On Holding AG | February 14, 2023 | 5,468,504 | 1.9% |
| Root, Inc. | February 14, 2023 | 138,977 | 1.5% |
| Yatsen Holding Ltd | February 14, 2023 | 300,560,602 | 19.1% |
| iQIYI, Inc. | July 11, 2022 | 149,075,912 | 5.0% |
| Apellis Pharmaceuticals, Inc. | February 14, 2022 | ? | ? |
| Beam Therapeutics Inc. | February 14, 2022 | ? | ? |
| Futu Holdings Ltd | February 14, 2022 | 2 | - |
View HHLR ADVISORS, LTD.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 4 | 2024-02-01 |
| 13F-HR | 2023-11-14 |
View HHLR ADVISORS, LTD.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.